Southern California Infusion Therapy | SoCal Snapshot
Southern California Infusion Therapy | SoCal Snapshot

Welcome to the inaugural edition of the SoCal Quarterly, your new source of updates and insights directly from us at SoCal Infusions! As part of our ongoing commitment to enhancing patient care and support, we are excited to announce not only the launch of the quarterly newsletter but also a comprehensive revamp of our website. These initiatives are designed to provide enriched content and improved resources for both patients and professionals, facilitating better access to our services and the latest in medical treatment news.

Ketamine: A Beacon of Hope

The medical community’s perspective on ketamine has evolved dramatically. Once known merely as an anesthetic and controversially as a recreational drug, it has emerged as a beacon of hope against treatment-resistant depression, anxiety disorders, PTSD, chronic pain, and more. With each passing year, research continues to unlock its potential, making it a lead in the fight against conditions that have long challenged traditional treatment approaches.

Transformative Research

Recent advancements in ketamine research have significantly contributed to our understanding and application of this treatment. Key highlights include:

  • Repeated Ketamine Infusions for Treatment-Resistant Depression: This study compared repeated ketamine infusions to a single dose for depression that didn’t respond to other treatments. Researchers found that multiple infusions were more effective than a single dose or placebo in reducing symptoms. The positive effects lasted up to 6 weeks after the final infusion in some patients.1
  • Large-Scale Analysis Confirms Ketamine’s Rapid Action Against Depression: Researchers analyzed data from multiple studies on ketamine infusion for depression. This analysis confirmed ketamine’s rapid antidepressant effect, with significant improvement in depression scores within a day of the infusion. Additionally, the analysis suggests these effects can last for at least a week. 2
  • Long-Term Outcomes of Ketamine Treatment for Depression: This research examined the long-term effects of ketamine infusions for depression. While not everyone responded to the treatment, those who did showed sustained improvement in symptoms for at least 6 months, even with reduced infusion frequency over time. 3

Advancements in Chronic Pain Management

Ketamine’s utility extends beyond mental health; it is also a promising alternative in chronic pain management, especially for nerve-related conditions. Its mechanism as an NMDA receptor antagonist offers a significant reduction in pain without the dependency risks associated with opioids, marking it as a safer and more effective pain management solution.


Book Your Free Consultation

Revolutionizing Treatment Accessibility

The way ketamine is administered has evolved, enhancing its accessibility and patient safety. The FDA’s approval in 2019 of the esketamine nasal spray (brand name Spravato) for treatment-resistant depression marked a significant milestone in making this powerful treatment more accessible through user-friendly formats like nasal sprays and sublingual tablets.

Looking Forward

With these ongoing advancements and the supportive research backing ketamine’s diverse applications, we are entering a new era of medical therapy. Ketamine’s role in providing rapid relief from severe symptoms is becoming increasingly recognized, establishing it as a critical component of contemporary therapeutic strategies.

At SoCal Infusions, we are proud to be at the forefront of this exciting field, continuously working to improve our services and expand our understanding of effective treatments. We invite you to stay connected through our revamped website and quarterly updates, ensuring you have the latest information and support at your fingertips.

Contact Us Today!


1- A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression. 26 June 2020

2- International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators. 27 December 2022

3- Ketamine treatment for depression: a review. 15 April 2022

Request Your Free Consultation Now